Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

It was a landmark year for medical advancements in 2024, bringing a wave of innovative treatments that promise to reshape ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

While the condition remains incurable, there are a ... Nov. 19, 2024 — Common cardiovascular drugs are linked to a lower risk of dementia in older age, according to a new ... Earlier Diabetes ...

The research team referred to the “valuable insights” that could help reduce instances of cognitive impairment.

Researchers found that combining cardiovascular disease drug classes, particularly antihypertensives, can reduce risk of dementia.

Carty recommends preparing a medication list that includes all the prescribed and over ... seizure disorders, allergies to medications and dementia patients who may wander off. You can also set up a ...

Ozempic could help patients with advanced Alzheimer’s disease, scientists believe. Trials are underway examining the impact ...